Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sage May Be Forced To Simplify Brexanolone Dosing Regimen

Nov 09 2018

• By Derrick Gingery

Infusion of a hospital

Related Content

Sage's Postpartum Depression Drug Brexanolone Faces Loss-Of-Consciousness Questions

Oct 31 2018

Sage's Brexanolone Could Be Transformative, But Only In Controlled Settings, US FDA Panel Says

Nov 02 2018

Related Companies

Sage Therapeutics, Inc.

Additional Topics

United States Advisory Committees Drug Review Regulation Neurology BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window